Clinical Trial Update: Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of piromelatine in patients with mild Alzheimer's disease; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Piromelatine

Snippet

Sponsor: Neurim Pharmaceuticals Ltd. | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-07-05